<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65379">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01819038</url>
  </required_header>
  <id_info>
    <org_study_id>chula</org_study_id>
    <nct_id>NCT01819038</nct_id>
  </id_info>
  <brief_title>Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury</brief_title>
  <acronym>EarlyRRT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research project is a prospective study  to compare mortality between early renal
      replacement therapy (RRT) and  late renal replacement therapy by using plasma neutrophil
      gelatinase associated lipocalin (pNGAL) as a tool in decision- making.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>mortality rate</measure>
    <time_frame>28 day</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>ventilator free-days</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>hemodialysis free-days</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Renal Failure</condition>
  <arm_group>
    <arm_group_label>High NGAL and early RRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NGAL level &gt; 400 ng/ml and start continuous renal replacement therapy early</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High NGAL and late RRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NGAL &gt; 400 ng/ml and start continuous renal replacement therapy late</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low NGAL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NGAL &lt; 400 ng/ml and starting continuous renal replacement therapy follow with absolute indication</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>continuous renal replacement therapy</intervention_name>
    <arm_group_label>High NGAL and early RRT</arm_group_label>
    <arm_group_label>High NGAL and late RRT</arm_group_label>
    <arm_group_label>Low NGAL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given his/her informed and signed consent

          -  patients with acute kidney injury in the intensive care ward.

        Exclusion Criteria:

          -  The patient refuses to sign the consent

          -  The patient is pregnant, parturient, or breastfeeding

          -  End stage renal disease

          -  Chronic renal failure

          -  previous kidney transplant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nattachai Srisawat, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nattachai Srisawat, M.D.</last_name>
    <phone>66818361891</phone>
    <email>drnattachai@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chotima Saetia, M.D.</last_name>
      <phone>66875151513</phone>
      <email>drchotima@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 22, 2013</lastchanged_date>
  <firstreceived_date>March 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Nattachai Srisawat ,M.D.</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
